The former chief business officer of U.S. biotechnology company Osiris Therapeutics Inc has agreed to pay a US$40,000 civil penalty for lying to auditors, the Securities and Exchange Commission said on Thursday.
Ex-US biotech executive fined for lying to auditors, charges dropped against CFO: SEC
